Concepedia

Publication | Open Access

A Phase I Study of Binimetinib (MEK162) Combined with Pexidartinib (PLX3397) in Patients with Advanced Gastrointestinal Stromal Tumor

DOIFull Paper Access

41

Citations

22

References

2019

Year

Evan Rosenbaum, Ciara M. Kelly, Sandra P. D’Angelo, Mark A. Dickson, Mrinal M. Gounder, Mary Louise Keohan, Sujana Movva, Mercedes M. Condy, Travis E. Adamson, Chloe Mcfadyen,
The Oncologist

Abstract

Pexidartinib combined with binimetinib was tolerable, and meaningful clinical activity was observed in two imatinib-refractory patients.

References

YearCitations

Page 1